Rhenman & Partners Asset Management AB as of Dec. 31, 2019
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 94 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Esperion Therapeutics (ESPR) | 4.3 | $39M | 660k | 59.63 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $35M | 160k | 218.95 | |
| Novocure Ltd ord (NVCR) | 3.2 | $30M | 350k | 84.27 | |
| Horizon Therapeutics | 3.1 | $28M | 775k | 36.20 | |
| Humana (HUM) | 2.7 | $25M | 67k | 366.52 | |
| Nektar Therapeutics (NKTR) | 2.6 | $24M | 1.1M | 21.59 | |
| Bristol Myers Squibb (BMY) | 2.4 | $22M | 340k | 64.19 | |
| Boston Scientific Corporation (BSX) | 2.2 | $20M | 452k | 45.22 | |
| Cigna Corp (CI) | 2.1 | $19M | 95k | 204.49 | |
| Anthem (ELV) | 2.0 | $19M | 62k | 302.03 | |
| Abbvie (ABBV) | 2.0 | $19M | 210k | 88.54 | |
| Abbott Laboratories (ABT) | 2.0 | $18M | 208k | 86.86 | |
| BioMarin Pharmaceutical (BMRN) | 1.9 | $18M | 210k | 84.55 | |
| Intra Cellular Therapies (ITCI) | 1.9 | $17M | 500k | 34.31 | |
| UnitedHealth (UNH) | 1.9 | $17M | 58k | 293.98 | |
| Aerie Pharmaceuticals | 1.9 | $17M | 700k | 24.17 | |
| Mirati Therapeutics | 1.8 | $16M | 125k | 128.86 | |
| Myokardia | 1.7 | $15M | 210k | 72.89 | |
| Alexion Pharmaceuticals | 1.7 | $15M | 141k | 108.15 | |
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $15M | 101k | 149.28 | |
| Livanova Plc Ord (LIVN) | 1.6 | $15M | 200k | 75.43 | |
| Abiomed | 1.6 | $15M | 87k | 170.59 | |
| Immunomedics | 1.6 | $15M | 700k | 21.16 | |
| Eli Lilly & Co. (LLY) | 1.6 | $15M | 111k | 131.43 | |
| Merck & Co (MRK) | 1.6 | $15M | 160k | 90.95 | |
| Medtronic (MDT) | 1.6 | $14M | 125k | 113.45 | |
| Seattle Genetics | 1.5 | $14M | 120k | 114.26 | |
| Iovance Biotherapeutics (IOVA) | 1.4 | $13M | 475k | 27.68 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $13M | 120k | 107.49 | |
| Glaukos (GKOS) | 1.4 | $13M | 235k | 54.47 | |
| Dermira | 1.3 | $12M | 800k | 15.16 | |
| Guardant Health (GH) | 1.3 | $12M | 155k | 78.14 | |
| Fibrogen (FGEN) | 1.3 | $12M | 275k | 42.89 | |
| Macrogenics (MGNX) | 1.3 | $12M | 1.1M | 10.88 | |
| Xencor (XNCR) | 1.2 | $11M | 310k | 34.39 | |
| Epizyme | 1.1 | $11M | 425k | 24.60 | |
| CVS Caremark Corporation (CVS) | 1.1 | $10M | 140k | 74.29 | |
| Hca Holdings (HCA) | 1.1 | $10M | 70k | 147.81 | |
| Regeneron Pharmaceuticals (REGN) | 1.1 | $10M | 27k | 375.48 | |
| Arena Pharmaceuticals | 1.1 | $10M | 220k | 45.42 | |
| EXACT Sciences Corporation (EXAS) | 1.1 | $9.9M | 107k | 92.48 | |
| Becton, Dickinson and (BDX) | 1.0 | $9.2M | 34k | 271.97 | |
| Axonics Modulation Technolog (AXNX) | 1.0 | $9.1M | 330k | 27.71 | |
| Edwards Lifesciences (EW) | 1.0 | $8.9M | 38k | 233.29 | |
| Centene Corporation (CNC) | 1.0 | $8.8M | 140k | 62.87 | |
| Amarin Corporation (AMRN) | 0.9 | $8.6M | 400k | 21.44 | |
| Silk Road Medical Inc Common (SILK) | 0.9 | $8.5M | 209k | 40.38 | |
| D Stemline Therapeutics | 0.9 | $8.1M | 760k | 10.63 | |
| Omnicell (OMCL) | 0.8 | $7.8M | 95k | 81.72 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $7.6M | 160k | 47.75 | |
| Alkermes (ALKS) | 0.8 | $7.5M | 370k | 20.40 | |
| Adverum Biotechnologies | 0.8 | $7.5M | 650k | 11.52 | |
| Intuitive Surgical (ISRG) | 0.8 | $7.1M | 12k | 591.17 | |
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $7.0M | 61k | 115.18 | |
| G1 Therapeutics (GTHX) | 0.8 | $7.0M | 263k | 26.43 | |
| Biohaven Pharmaceutical Holding | 0.8 | $6.8M | 125k | 54.44 | |
| Cooper Companies | 0.7 | $6.4M | 20k | 321.30 | |
| Dynavax Technologies (DVAX) | 0.7 | $6.2M | 1.1M | 5.72 | |
| Biogen Idec (BIIB) | 0.7 | $5.9M | 20k | 296.75 | |
| Sangamo Biosciences (SGMO) | 0.6 | $5.9M | 700k | 8.37 | |
| Incyte Corporation (INCY) | 0.6 | $5.7M | 65k | 87.32 | |
| Acceleron Pharma | 0.6 | $5.3M | 100k | 53.02 | |
| Bluebird Bio (BLUE) | 0.6 | $5.0M | 57k | 87.75 | |
| Aimmune Therapeutics | 0.6 | $5.0M | 150k | 33.47 | |
| Intercept Pharmaceuticals In | 0.5 | $5.0M | 40k | 123.92 | |
| Uniqure Nv (QURE) | 0.5 | $4.3M | 60k | 71.67 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $4.1M | 1.9M | 2.14 | |
| Revance Therapeutics (RVNC) | 0.4 | $4.1M | 250k | 16.23 | |
| Nanostring Technologies (NSTGQ) | 0.4 | $3.9M | 140k | 27.82 | |
| Meiragtx Holdings (MGTX) | 0.4 | $3.8M | 191k | 20.02 | |
| Sage Therapeutics (SAGE) | 0.4 | $3.6M | 50k | 72.20 | |
| Momenta Pharmaceuticals | 0.4 | $3.5M | 178k | 19.73 | |
| Radius Health | 0.4 | $3.4M | 170k | 20.16 | |
| Abeona Therapeutics | 0.4 | $3.3M | 1.0M | 3.27 | |
| Beigene (BGNE) | 0.4 | $3.3M | 20k | 165.75 | |
| Viewray (VRAYQ) | 0.3 | $3.2M | 750k | 4.22 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $3.1M | 75k | 40.97 | |
| Cellectis S A (CLLS) | 0.3 | $2.5M | 145k | 17.12 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $2.4M | 80k | 30.62 | |
| Viking Therapeutics (VKTX) | 0.2 | $1.6M | 200k | 8.02 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $1.1M | 300k | 3.62 | |
| Chevron Corporation (CVX) | 0.0 | $358k | 3.0k | 120.38 | |
| JPMorgan Chase & Co. (JPM) | 0.0 | $292k | 2.1k | 139.38 | |
| Exxon Mobil Corporation (XOM) | 0.0 | $269k | 3.9k | 69.80 | |
| Walt Disney Company (DIS) | 0.0 | $301k | 2.1k | 144.50 | |
| Wells Fargo & Company (WFC) | 0.0 | $284k | 5.3k | 53.87 | |
| International Business Machines (IBM) | 0.0 | $297k | 2.2k | 134.09 | |
| Qualcomm (QCOM) | 0.0 | $299k | 3.4k | 88.17 | |
| Ford Motor Company (F) | 0.0 | $271k | 29k | 9.29 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $230k | 2.8k | 81.97 | |
| Janus Henderson Group Plc Ord (JHG) | 0.0 | $260k | 11k | 24.42 | |
| Halliburton Company (HAL) | 0.0 | $203k | 8.3k | 24.46 | |
| Alphabet Inc Class A cs (GOOGL) | 0.0 | $214k | 160.00 | 1337.50 | |
| Nortonlifelock (GEN) | 0.0 | $224k | 8.8k | 25.57 |
